MestaMidin^®-sens (Solution) Instructions for Use

Marketing Authorization Holder

Tsitera LLC (Russia)

Manufactured By

Grotex, LLC (Russia)

ATC Code

D08AJ57 (Octenidine in combination with other drugs)

Active Substances

Phenoxyethanol (Ph.Eur. European Pharmacopoeia)

Octenidine (Rec.INN WHO registered)

Dosage Form

MestaMidin®-sens

Solution for topical and external use 1 mg+20 mg/1 ml: fl. 50 ml, 100 ml, 150 ml, 500 ml or 1000 ml

Dosage Form, Packaging, and Composition

Solution for topical and external use in the form of a transparent or almost transparent, colorless or slightly colored liquid, free of visible suspended particles.

Excipients: sodium chloride – 0.5 mg, cocamidopropyl betaine – 3 mg, sodium gluconate – 4 mg, anhydrous glycerol – 5 mg, 0.05M sodium hydroxide solution or 0.05M hydrochloric acid solution – to pH 5.0-7.0, purified water – to 1 ml.

50 ml – polymer bottles (1) with a dropper cap – cardboard boxes.
100 ml – polymer bottles (1) with a dropper cap – cardboard boxes.
50 ml – polymer bottles (1) with a pump and a pressure spray device with or without a folding cannula – cardboard boxes.
150 ml – polymer bottles (1) with a pump and a pressure spray device with or without a folding cannula – cardboard boxes.
500 ml – polymer bottles (1) – cardboard boxes.
1000 ml – polymer bottles (1) – cardboard boxes.

Clinical-Pharmacological Group

Antiseptic for external and topical use

Pharmacotherapeutic Group

Antiseptics and disinfectants; quaternary ammonium compounds

Pharmacological Action

Antiseptic for topical and external use. It has an antimicrobial effect.

It is active against gram-positive and gram-negative bacteria, lipophilic viruses, such as Herpes simplex virus and hepatitis B virus, as well as against yeast-like fungi and dermatophytes.

Indications

Treatment of the skin and mucous membranes before diagnostic and surgical procedures in pediatric, surgical, and obstetric-gynecological practice, in traumatology, proctology, dermatovenereology, otorhinolaryngology, dentistry; treatment of wound and burn surfaces; prevention of foot mycosis and interdigital mycosis.

ICD codes

Dosage Regimen

The drug is used externally and topically.

The area to be treated is alternately treated with 2 swabs generously moistened with the drug. The affected surface should be treated completely.

For easily accessible areas, the drug can be applied by spraying. The exposure time is at least 1-2 minutes.

For mouth rinsing, 20 ml of the drug is used; a second rinse is recommended after 20 seconds.

For the prevention of fungal diseases, the skin between the toes and the feet are treated with the drug 2 times/day (morning and evening).

The duration of treatment is up to 14 days.

In pediatric practice, the drug is used without age restrictions.

Adverse Reactions

Possible short-term burning at the application site; bitter taste when rinsing the mouth.

Contraindications

Hypersensitivity to the components of the drug.

Pediatric Use

In pediatric practice, the drug is used without age restrictions.

Special Precautions

When rinsing the mouth, the drug should not be swallowed.

Drug Interactions

The drug should not be used simultaneously with iodine-containing antiseptics.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.